GlassScriptPhysician profile
Lawrence Anthony Higgins
NPI 1811032006
$4,202.39
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,534 · 2020: $294 · 2021: $650 · 2022: $502 · 2023: $181 · 2024: $40.54.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,002.59 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $853.91 | 2019-2024 | Farxiga |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $342.12 | 2019-2022 | |
| Viiv Healthcare Company | $286.74 | 2019-2023 | Dovato |
| Amarin Pharma, INC. | $268.32 | 2019-2021 | |
| Astellas Pharma US INC | $237.52 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $213.98 | 2019-2020 | |
| Lilly USA, LLC | $162.71 | 2019-2022 | |
| Eisai INC. | $121.86 | 2019 | |
| Janssen Biotech, INC. | $119.87 | 2019 | |
| Novo Nordisk INC | $100.14 | 2019-2022 | |
| Janssen Products, LP | $99.99 | 2019 | |
| Glaxosmithkline, LLC. | $92.04 | 2021-2023 | Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $70.84 | 2019-2020 | |
| Horizon Therapeutics Plc | $53.84 | 2023 | Krystexxa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $49.73 | 2019 | |
| Merck Sharp & Dohme LLC | $36.37 | 2019 | |
| Emd Serono, INC. | $35.33 | 2019 | |
| Phadia US INC. | $19.41 | 2021 | |
| Antares Pharma, INC. | $19.04 | 2019 | |
| Metuchen Pharmaceuticals | $16.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.